recent
year
paradigm
shift
occur
cancer
research
identif
molecular
pathway
involv
cancer
initi
progress
aid
scientist
develop
new
therapi
accord
molecular
profil
patient
receptor
tyrosin
kinas
rtk
pharmaceut
attract
target
purpos
play
critic
role
tumor
format
regul
varieti
signaltransduct
pathway
within
cell
cmet
ligand
hepatocyt
growth
factor
hgf
mediat
epitheli
tissu
remodel
migrat
morphogenesi
cell
growth
differenti
angiogenesi
deregul
activ
cmetsign
pathway
multipl
mechan
like
activ
mutat
gene
amplif
heterodimer
report
correl
high
tumor
grade
lower
rate
surviv
cancer
moreov
cmet
found
marker
pancreat
cancer
stem
cell
made
suitabl
therapeut
target
cancer
treatment
met
receptor
belong
famili
rtk
heterodim
extracellular
transmembran
upon
bind
hgf
receptor
dimer
autophosphoryl
tyrosin
residu
kinas
domain
subunit
occur
lead
recruit
multipl
effector
protein
promot
activ
mapksign
statsign
faksign
pathway
etc
last
decad
smallmolecul
inhibitor
target
atpbind
site
kinas
domain
develop
test
clinic
trial
two
distinct
bind
pattern
propos
atpcompetit
inhibitor
type
compound
eg
bind
activ
dfgin
conform
interact
met
hing
region
tyr
activ
loop
although
specif
display
limit
activ
toward
tyr
mutat
type
ii
compound
eg
less
select
bind
inact
dfgout
conform
form
conform
chang
side
chain
evidenc
scientif
literatur
great
interest
screen
natur
product
drug
develop
report
natur
product
great
divers
novel
chemic
structur
render
use
new
inhibitor
accordingli
inhibitor
deriv
natur
product
sometim
call
fourth
gener
inhibitor
actual
natur
compound
deriv
constitut
anticanc
drug
addit
phytochem
use
increasingli
mani
reason
includ
low
cost
fewer
advers
effect
welltoler
bodi
thu
phytochem
discov
promis
compound
prevent
treatment
revers
drug
resist
cancer
moreov
previou
investig
reveal
flavonoid
modul
hgfcmet
axi
cancer
cell
intermolecular
contact
unknown
nowaday
molecular
dock
wellaccept
comput
method
structurebas
drug
design
identifi
novel
hit
molecul
employ
score
function
evalu
ligand
bind
orient
affin
convent
molecular
dock
differ
pose
predict
identifi
correct
pose
imposs
agreement
dock
pose
increas
accuraci
reduc
fals
posit
notabl
virtual
screen
object
consensu
dock
enhanc
ligand
pose
predict
one
score
algorithm
houston
et
al
report
signific
improv
pose
predict
accuraci
achiev
use
autodock
vina
case
interestingli
percentag
increas
three
dock
program
autodock
vina
dock
use
simultan
worthi
note
lamarckian
genet
algorithm
amberforcefieldbas
score
function
implement
autodock
vina
respect
berri
et
al
carri
multistep
autodock
vinaglidegold
consensu
dock
procedur
identifi
novel
inhibitor
human
coronaviru
valid
md
simul
howev
recent
studi
tuccinardi
et
al
focus
reliabl
consensu
dock
result
bind
pose
predict
use
ten
dock
procedur
studi
use
consensu
dock
procedur
screen
natur
occur
plantbas
anticanc
npact
databas
purpos
inform
regard
npact
entri
obtain
zinc
databas
follow
consensu
dock
md
simul
molecular
mechan
surfac
area
mmpbsa
bind
energi
calcul
perform
elucid
bind
mode
hit
compound
novel
cmet
kinas
inhibitor
threedimension
readytodock
format
ligand
avail
npact
databas
retriev
zinc
databas
http
zincdockingorg
januari
zinc
emerg
widelyus
databas
purchas
compound
suitabl
virtual
screen
use
physicochem
properti
ligand
select
conform
lipinski
rule
five
veber
rule
druglik
molecul
oral
bioavail
crystal
structur
activ
conform
cmet
kinas
domain
pdb
id
inact
conform
pdb
id
retriev
protein
data
bank
http
wwwrcsborgpdbhomehomedo
prepar
dock
calcul
elimin
hetero
atom
water
molecul
thereaft
miss
residu
protein
structur
modifi
use
model
base
origin
fasta
sequenc
repres
structur
cmet
autodock
tool
adt
use
merg
nonpolar
hydrogen
carbon
atom
comput
gasteig
charg
rotat
bond
gasteig
charg
also
assign
util
adt
select
ligand
autodock
vina
use
dock
structur
default
paramet
top
rank
ligand
dock
use
autodock
grid
box
point
space
defin
center
ligand
activ
site
run
dock
use
lamarckian
ga
number
paramet
set
except
number
lamarckian
genet
algorithm
run
set
paramet
consid
default
valu
dock
studi
residu
cmet
atpbind
site
allow
flexibl
lowest
energi
conform
autodock
vina
result
largest
cluster
autodock
select
result
dock
structur
root
mean
squar
deviat
rmsd
calcul
use
assess
dock
pose
autodock
vina
autodock
describ
houston
et
al
consequ
pose
rmsd
reject
gener
molecular
represent
proteinligand
complex
pymol
molecular
graphic
system
v
use
zincpharm
http
zincpharmercsbpittedu
also
use
identifi
pharmacophor
featur
hit
molecul
gromac
use
perform
md
simul
forc
field
paramet
perform
md
simul
best
autodock
vina
result
consid
initi
conform
simul
electrostat
potenti
esp
charg
drug
candid
comput
employ
optim
geometri
p
scf
tight
pop
mk
iop
calcul
esp
restrain
electrostat
potenti
resp
method
employ
assign
atom
charg
obtain
ligand
topolog
file
base
gener
amber
forc
field
antechamb
use
distanc
nm
set
cubic
box
water
molecul
solut
steepest
descent
algorithm
appli
maximum
forc
whole
system
kjmol
ps
nvt
npt
ensembl
complex
simul
equilibr
k
temperatur
bar
pressur
respect
final
simul
run
carri
ns
time
step
fs
vrescal
temperatur
pressur
coupl
algorithm
ewald
pme
algorithm
util
calcul
longrang
electrostat
linear
constraint
solver
linc
method
use
constrain
coval
bond
length
nm
cutoff
set
van
der
waal
interact
vmd
pymol
molecular
graphic
system
v
use
visual
trajectori
gener
imag
respect
bindingfre
energi
calcul
base
mmpbsa
method
estim
use
gmmpbsa
tool
snapshot
save
everi
ps
last
ns
md
trajectori
consid
calcul
energi
term
solut
solvent
vacuum
dielectr
constant
set
respect
polar
solvat
calcul
solventaccess
surfac
area
sasa
model
also
use
comput
nonpolar
solvat
energi
schemat
procedur
consensu
dock
shown
fig
compil
plantderiv
compound
avail
zinc
databas
current
widelyus
databas
virtual
screen
filter
accord
lipinski
veber
rule
physicochem
criteria
employ
select
desir
compound
membran
permeabl
well
easili
absorb
human
bodi
process
ligand
set
dock
consensu
dock
method
mention
earlier
method
reason
particularli
fund
purchas
compound
limit
calcul
rmsd
bind
mode
predict
autodock
vina
complex
produc
small
set
molecul
ligand
two
hit
line
gooddock
score
estim
presenc
essenti
interact
key
residu
atpbind
site
consid
evalu
structur
two
hit
compound
alongsid
molecular
weight
shown
tabl
steroid
lacton
molecular
weight
gmol
chemic
consist
moieti
unsatur
lacton
side
chain
play
crucial
role
biolog
activ
regard
orthodiphenol
diterpen
gmol
molecular
weight
structur
abietan
carbon
skeleton
lacton
moieti
orient
across
central
ring
order
reject
fals
posit
crucial
evalu
bind
mode
affin
preliminari
hit
compound
tabl
show
dock
result
associ
interact
profil
detail
interestingli
exhibit
higher
affin
comparison
inact
conform
cmet
evidenc
autodock
bind
energi
kcalmol
analysi
interact
pattern
show
phenol
hydroxyl
group
engag
two
hydrogen
bond
carboxyl
group
amino
group
hing
region
hydrophob
contact
present
central
hydrophob
region
residu
like
two
hydrophob
subpocket
activ
loop
involv
hydrophob
interact
fig
case
bound
activ
conform
form
hydrogen
bond
residu
hing
region
typic
characterist
kinas
inhibitor
target
atpbind
site
instead
hydrophob
interact
found
suggest
lower
bind
affin
nm
altern
residu
compris
hydrophob
subpocket
well
activ
loop
involv
hydrophob
interact
side
chain
along
carboxyl
group
catalyt
loop
also
form
bident
hbond
potent
inhibitor
illustr
fig
furthermor
fig
show
pharmacophor
featur
hit
molecul
reveal
compound
hydrogen
donor
hd
acceptor
ha
featur
lead
hydrogen
bond
n
result
strong
interact
hydroxyl
group
hd
properti
addit
scaffold
five
hydrophob
featur
regard
backbon
four
hydrophob
one
aromat
featur
wherea
ha
properti
tend
approach
besid
hd
ha
featur
form
hydrogen
bond
hd
activ
site
although
select
two
complex
accord
consensu
dock
bound
bound
compar
stabil
bind
affin
aforement
compound
comput
apo
form
cmet
proteinligand
complex
subject
md
simul
mmpbsa
bind
energi
calcul
method
given
autodock
vina
believ
superior
ligand
pose
predict
autodock
dock
result
vina
lowest
bind
energi
chosen
md
simul
note
dock
simul
provid
singl
snapshot
interact
ligand
protein
rigid
semiflex
dock
thu
order
gain
deeper
insight
effect
protein
structur
chang
flexibl
complex
interact
profil
md
simul
perform
rmsd
comparison
initi
structur
indic
apo
state
experienc
continu
fluctuat
rise
nm
end
simul
period
upon
bind
activ
site
averag
valu
conform
chang
increas
nm
chang
neglig
fig
consider
without
ligand
rmsd
valu
increas
nm
first
ns
thereaft
receptor
reach
plateau
last
ns
bind
stabil
function
time
also
analyz
shown
system
converg
well
rang
nm
compar
fig
howev
obviou
rmsd
valu
smaller
observ
around
ns
rmsd
valu
underw
notic
fluctuat
due
lacton
ring
rotat
respect
remain
stabl
till
end
fig
howev
achiev
rel
stabl
coordin
throughout
entir
simul
process
result
also
observ
initi
mdaverag
structur
superimpos
fig
investig
residu
mobil
ligandbound
unbound
form
root
mean
squar
fluctuat
rmsf
individu
residu
also
monitor
case
shown
fig
bind
hit
molecul
induc
remark
chang
flexibl
atpbind
site
residu
rel
protein
apo
state
particular
fluctuat
minim
state
thereaft
protein
structur
compact
analyz
use
ggyrat
util
gromac
softwar
fig
tabl
shown
apo
state
protein
stabl
obviou
structur
expans
contract
wherea
led
lower
rg
valu
especi
complex
within
rang
nm
addit
obviou
expans
occur
bound
ns
tabl
present
inform
regard
hydrogen
bond
form
throughout
trajectori
proteinligand
complex
percentag
hbond
presenc
last
ns
md
simul
measur
examin
stabil
though
contact
popul
simul
time
list
summar
tabl
form
hydrogen
bond
group
occup
inact
form
complex
form
two
hydrogen
bond
main
chain
nitrogen
oxygen
atom
hing
region
respect
main
determin
overal
stabil
complex
two
hydrogen
bond
main
chain
oxygen
atom
detect
occup
amino
group
particip
hbond
interact
recent
studi
report
mmpbsa
method
simul
techniqu
estim
biomolecular
interactionfre
energi
although
increas
comput
cost
provid
accur
inform
energyscor
function
use
dock
softwar
rescor
toprank
hit
five
hundr
snapshot
extract
ns
equal
interv
select
input
analysi
report
tabl
result
show
select
molecul
higher
bind
affin
kjmol
respect
toward
wherea
latter
structur
show
kjmol
respect
though
differ
consider
addit
less
neg
bind
energi
complex
among
differ
energi
term
contribut
proteinligand
bind
energi
van
der
waal
e
vdw
electrostat
e
ele
sasa
energi
play
crucial
role
bind
energi
complex
stabil
nevertheless
polar
solvat
energi
g
ps
opposit
effect
caus
bind
energi
depend
unfavor
posit
valu
regard
van
der
waal
energi
contribut
neg
free
energi
electrostat
energi
complex
besid
complex
van
der
waal
interact
predomin
total
bindingfre
energi
wherea
complex
unfavor
contribut
polar
solvat
energi
signific
use
consensu
dock
approach
virtual
screen
compound
retriev
npact
databas
activ
inact
state
cmet
kinas
domain
yield
select
two
hit
molecul
use
md
simul
stabil
complex
evalu
result
show
protein
ligand
backbon
achiev
stabil
ns
nevertheless
experienc
stabl
conform
case
entir
simul
process
given
hydrogen
bond
residu
hing
region
hallmark
kinas
domain
inhibitor
analysi
show
hit
molecul
form
hydrogen
bond
key
residu
activ
form
summari
base
hydrogen
bond
analysi
mmpbsa
studi
predict
plausibl
inhibitor
activ
state
cmet
line
dock
result
show
effect
toward
activ
cmet
kinas
domain
inact
form
due
higher
bind
energi
result
disclos
use
overcom
metaddict
cancer
